Asterab IT
Composition
Rabeprazole 20mg + Itopride 150mg Extended Release Capsules
Indication
Rabeprazole + Itopride, marketed as Asterab IT, is a combination medication specifically formulated to treat gastroesophageal reflux disease (GERD) and peptic ulcer disease. Asterab IT capsules, containing rabeprazole gastro-resistant and itopride prolonged release, combine the acid-reducing properties of rabeprazole (20mg) with the prokinetic effects of itopride (150mg). This formulation is designed to provide effective relief from acid-related indigestion, heartburn, and associated symptoms by reducing stomach acid production and enhancing digestive tract motility.
Asterab IT capsules work by inhibiting the enzyme responsible for acid secretion in the stomach, thereby alleviating symptoms and promoting healing of damaged tissues caused by excessive acid. Simultaneously, itopride acts on the upper digestive tract and the brain's vomiting control centers, stimulating gastric and intestinal movement to facilitate smoother food passage and prevent nausea.
Patients prescribed Asterab IT (rabeprazole 20mg + itopride 150mg) experience comprehensive relief from GERD and peptic ulcers through its dual-action mechanism of acid suppression and improved digestive motility. Asterab IT capsules are recognized for their effectiveness and are widely recommended for individuals requiring reliable management of acid reflux and related digestive conditions.
Contraindication
Diarrhoea, Headache, Dizziness, Flatulence, Weakness, Nausea, Vomiting, Abdominal pain.
Storage
Cool & Dry Place
Dosage
As directed by a Medical Practitioner or Physician.
Inquire Now